Resultados da busca - Mayur Ramesh
- Mostrando 1 - 20 resultados de 31
- Ir para a próxima página
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent<i>Clostridium difficile</i>Infection: Results of the PUNCH CD Study por Robert Orenstein, Erik R. Dubberke, Robert Hardi, Arnab Ray, Kathleen M. Mullane, Darrell S. Pardi, Mayur Ramesh
Publicado em 2015Artigo -
9
593. Utility of Microbiologic Testing Obtained via Bronchoalveolar Lavage on Asymptomatic Lung Transplant Recipients: A Quality Improvement Study por Dillon, William, Parraga Acosta, Tommy J, Failla, Andrew J, Corrales, Julio, Mayur, Ramesh, Alangaden, George J
Publicado em 2021Texto -
10
-
11
247. Evaluation of the T2Candida Panel as an Antifungal Stewardship Tool in Transplant and Non-Transplant Patients at a Tertiary Care Center por Sarfraz. Chaudhry, Zohra, Vahia, Amit T, Kathuria, Priya, Doyon-Reale, Nicole, Mayur, Ramesh, Abreu Lanfranco, Odaliz, Del Busto, Ramon, Alangaden, George J
Publicado em 2019Texto -
12
Clostridium difficile Infection in Liver Transplant Recipients: A Retrospective Study of Rates, Risk Factors and Outcomes por Chetan Mittal, Syed Adeel Hassan, Samia Arshad, Sravan Jeepalyam, Stefania Bruni, M Miceli, Gordon Jacobsen, Marwan Abouljoud, I Bajjoka, Mayur Ramesh, George Alangaden
Publicado em 2014Artigo -
13
497. Moderate Versus High Dose Corticosteroids in Adult Patients with Severe COVID-19: Less Is More por Joshi, Seema, Soman, Sana, Jain, Saniya, Yako, Atheel, Hojeij, Marwa, Massoud, Louis, Alsaadi, Ayman, Smith, Zachary R, Alangaden, George J, Kenney, Rachel, Mayur, Ramesh
Publicado em 2021Texto -
14
1377. Impact of Pre-Transplant Infectious Diseases Wellness Visit on Vaccine Uptake in Solid Organ Transplant Candidates por Parraga, Tommy J, McCorquodale, Jennifer, Greenlee, Sage, Osborn, Zachary, Hanna, Zachary W, Williams, Jonathan D, Lanfranco, Odaliz Abreu, Mayur, Ramesh, Alangaden, George J
Publicado em 2021Texto -
15
Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab por Austin Morrison, Joseph M. Johnson, Kristin Griebe, Mathew Jones, John Stine, Laura Hencken, Long To, Monica Bianchini, Amit Vahia, Jennifer Swiderek, Mayur Ramesh, Michael A. Peters, Zachary Smith
Publicado em 2020Artigo -
16
1060. Pritelivir in Immunocompromised Patients with Mucocutaneous Acyclovir-Resistant Herpes Simplex Virus-Infections – First Case Series por Albrecht, Kim WorkowskiJoerg, Avery, Robin K, Avery, Robin K, Chandrasekar, Pranatharthi, Chemaly, Roy F, Issa, Nicolas C, Kotton, Camille, Kotton, Camille, Kumar, Princy N, Mayur, Ramesh, Ramgopal, Moti, Schiffer, Joshua, Wald, Anna, Ison, Michael G
Publicado em 2021Texto -
17
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit por Geehan Suleyman, Raef Fadel, Kelly Malette, Charles Hammond, Hafsa Abdulla, Abigail Entz, Zachary Demertzis, Zachary R. Hanna, Andrew J Failla, Carina Dagher, Zohra Chaudhry, Amit Vahia, Odaliz Abreu Lanfranco, Mayur Ramesh, Marcus Zervos, George Alangaden, Joseph Miller, Indira Brar
Publicado em 2020Revisão -
18
Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: A cohort study por Zohra Chaudhry, Jonathan Williams, Amit Vahia, Raef Fadel, Tommy Parraga Acosta, Rohini Prashar, Pritika Shrivastava, Nadeen Khoury, Julio Pinto Corrales, Celeste T. Williams, Shunji Nagai, Marwan Abouljoud, Milagros Samaniego, Odaliz Abreu-Lanfranco, Ramon Del Busto, Mayur Ramesh, Anita Patel, George Alangaden
Publicado em 2020Artigo -
19
730. A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Ridinilazole Compared with Vancomycin for the Treatment of <i>Clostridioides difficile</i> Inf... por Pablo C. Okhuysen, Mayur Ramesh, Kevin W. Garey, Thomas Louie, Julián Torre Cisneros, Alena Stychneuskaya, Nino Kiknadze, Jianling LI, Esther Duperchy, Professor Mark H Wilcox, José G. Montoya, Lori Styles, Fong Clow, Danelle F. James, Erik R. Dubberke, Cláudia Murta de Oliveira, Christophe Van Steenkiste
Publicado em 2022Artigo -
20
A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of <i>Clostridioides difficile</i> Infection: Clinical Outcomes With M... por Pablo C. Okhuysen, Mayur Ramesh, Thomas Louie, Nino Kiknadze, Julián Torre‐Cisneros, Cláudia Murta de Oliveira, Christophe Van Steenkiste, Alena Stychneuskaya, Kevin W. Garey, Julia Garcia‐Diaz, Jianling Li, Esther Duperchy, Betty Chang, Juthamas Sukbuntherng, José G. Montoya, Lori Styles, Fong Clow, Danelle F. James, Erik R. Dubberke, Mark H. Wilcox
Publicado em 2024Artigo
Ferramentas de busca:
Assuntos relacionados
Medicine
Internal medicine
Disease
Biology
Coronavirus disease 2019 (COVID-19)
Infectious disease (medical specialty)
Pediatrics
Antibiotics
Immunology
Microbiology
Adverse effect
Clostridium difficile
Vaccination
Virology
Clinical endpoint
Cohort
Gastroenterology
Genetics
Mechanical ventilation
Odds ratio
Randomized controlled trial
Cohort study
Emergency medicine
Environmental health
Intensive care medicine
Intensive care unit
Logistic regression
Outbreak
Population
Retrospective cohort study